Wednesday, May 05, 2004

Maybe an End to the 'Free Market for Me, But Not for Thee' Principle?



Real competition in U.S. can lower drug costs

Prescription drug prices in the USA are 67% higher on average than in Canada. No wonder Congress is feeling the heat from consumers to end a ban on importing U.S.-made medicine from other nations. On Tuesday, Health and Human Services Secretary Tommy Thompson predicted lawmakers soon would do just that.

Yet lifting the ban would save consumers only 1% over 10 years, the Congressional Budget Office estimated last week. If the ban were lifted only for Canada, the savings would be negligible, it said. The reason: While Canada can provide deep discounts for the small number of Americans who now buy drugs across the border, it would be overwhelmed by a spike in U.S. demand. Drugmakers already are cutting exports to Canada to curb U.S. discount buying.

more ...

i don't think the estimate of 1% savings over the next 10 years is accurate. if the savings were so paltry, then ordering drugs from abroad wouldn't be so popular. i think this is based on the assumption that big pharma will cut back on exports to other countries to prevent americans from getting a good deal on their meds, which sounds like a load of hot air. they are just posturing. there's no way they are going to piss off a customer as big as the canadian government.

No comments: